The Prognostic and Therapeutic Implications of the Chemoresistance Gene BIRC5 in Triple-Negative Breast Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5180, doi. 10.3390/cancers14215180
- By:
- Publication type:
- Article
Works matching DE "IXABEPILONE"
Results: 14
1
2
Microtubule-Interfering Drugs: Current and Future Roles in Epithelial Ovarian Cancer Treatment.
- Published in:
- Cancers, 2021, v. 13, n. 24, p. 6239, doi. 10.3390/cancers13246239
- By:
- Publication type:
- Article
3
Chemotherapy reaction induced by ixabepilone, a microtubule stabilizing agent, mimicking extramammary Paget's disease in a patient with breast carcinoma.
- Published in:
- Journal of Cutaneous Pathology, 2016, v. 43, n. 12, p. 1215, doi. 10.1111/cup.12833
- By:
- Publication type:
- Article
4
5-FU and ixabepilone modify the microRNA expression profiles in MDA-MB-453 triple-negative breast cancer cells.
- Published in:
- Oncology Letters, 2014, v. 7, n. 2, p. 541, doi. 10.3892/ol.2013.1697
- By:
- Publication type:
- Article
5
Selected Abstracts presented at the 8th Annual Meeting of the Hematology/Oncology Pharmacy Association, 21–24 March 2012, Orlando, Florida, USA.
- Published in:
- 2012
- Publication type:
- Abstract
6
A phase I study of oral ixabepilone in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 1071, doi. 10.1007/s00280-014-2443-7
- By:
- Publication type:
- Article
7
Neurotoxicity as a Prognostic Factor in Patients with Metastatic Breast Cancer Treated with Ixabepilone as a First-Line Therapy.
- Published in:
- Oncology, 2015, v. 88, n. 3, p. 180, doi. 10.1159/000367808
- By:
- Publication type:
- Article
8
Ixabepilone-induced mitochondria and sensory axon loss in breast cancer patients.
- Published in:
- Annals of Clinical & Translational Neurology, 2014, v. 1, n. 9, p. 639, doi. 10.1002/acn3.90
- By:
- Publication type:
- Article
9
Zampanolide, a Microtubule-Stabilizing Agent, Is Active in Resistant Cancer Cells and Inhibits Cell Migration.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 5, p. 971, doi. 10.3390/ijms18050971
- By:
- Publication type:
- Article
10
Epothilones in epithelial ovarian, fallopian tube, or primary peritoneal cancer: a systematic review.
- Published in:
- OncoTargets & Therapy, 2015, v. 8, p. 2187, doi. 10.2147/OTT.S77342
- By:
- Publication type:
- Article
11
A Phase II Multi-Center Study of Bevacizumab in Combination with Ixabepilone in Subjects with Advanced Renal Cell Carcinoma.
- Published in:
- Oncologist, 2017, v. 22, n. 8, p. 888, doi. 10.1634/theoncologist.2017-0211
- By:
- Publication type:
- Article
12
Phase II Clinical Trial of Ixabepilone in Metastatic Cervical Carcinoma.
- Published in:
- Oncologist, 2015, v. 20, n. 7, p. 725, doi. 10.1634/theoncologist.2015-0104
- By:
- Publication type:
- Article
13
Astragalus membranaceus–Derived Anti-Programmed Death-1 Monoclonal Antibodies with Immunomodulatory Therapeutic Effects against Tumors.
- Published in:
- BioMed Research International, 2020, p. 1, doi. 10.1155/2020/3415471
- By:
- Publication type:
- Article
14
Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells.
- Published in:
- 2016
- By:
- Publication type:
- journal article